CERVIDX Trademark

Trademark Overview


On Wednesday, September 20, 2006, a trademark application was filed for CERVIDX with the United States Patent and Trademark Office. The USPTO has given the CERVIDX trademark a serial number of 79036313. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 21, 2016. This trademark is owned by mtm laboratories AG. The CERVIDX trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Chemical preparations and reagents for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant cancerous conditions, malignant cancerous conditions, cancer and inborn deficiencies for scientific or research use

Pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous, conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents for detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic preparations, diagnostic immunocytoc...

Laboratory equipment for diagnostic purposes, namely, test tubes, multiwell test plates, multiwell ELISA (enzyme linked immunosorbent assay) plates and chromatography columns for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples

Medical diagnostic testing machines, namely, point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno-assay machines, diagnostic ELISA (enzyme linked immunosorbent assay) testing machines, diagnostic immuno-chromatographic machines, all of the aforementioned machines being for use in analyzing and providing diagnostic test results and used in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic equipment for medical purposes, namely, syringes, needles, brushes, spatulas and sample receptacles fo...

Scientific analysis in the fields of chemistry, biology and molecular biology; laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and medical diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services

Medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds
cervidx

General Information


Serial Number79036313
Word MarkCERVIDX
Filing DateWednesday, September 20, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, September 21, 2016
Registration Number3476787
Registration DateTuesday, July 29, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2008

Trademark Statements


Goods and ServicesChemical preparations and reagents for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant cancerous conditions, malignant cancerous conditions, cancer and inborn deficiencies for scientific or research use
Goods and ServicesPharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous, conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents for detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic preparations, diagnostic immunocytochemical preparations, diagnostic immunohistochemical preparations, diagnostic histology preparations, diagnostic cytology preparations, diagnostic liquid-immuno-assay preparations, diagnostic solid-phase immuno-assay preparations, diagnostic testing strips, diagnostic dip-stick tests, diagnostic preparations for use at point of care, diagnostic lateral-flow assay preparations, diagnostic flow-through assay preparations, diagnostic immuno-chromatographic preparations; diagnostic equipment for medical purposes, namely, strips, cotton sticks, swabs, cotton and tampons for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies as indicated above
Goods and ServicesLaboratory equipment for diagnostic purposes, namely, test tubes, multiwell test plates, multiwell ELISA (enzyme linked immunosorbent assay) plates and chromatography columns for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples
Goods and ServicesMedical diagnostic testing machines, namely, point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno-assay machines, diagnostic ELISA (enzyme linked immunosorbent assay) testing machines, diagnostic immuno-chromatographic machines, all of the aforementioned machines being for use in analyzing and providing diagnostic test results and used in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic equipment for medical purposes, namely, syringes, needles, brushes, spatulas and sample receptacles for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic nucleic acid detection machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic nucleic acid amplification machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic immuno-histology machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; diagnostic immuno-cytology machines for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; medical diagnostic apparatus and instruments, namely, hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic electromagnetic-resonance, histological, microscopic and in-vivo imaging machines, all for for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies; automated and non-automated cellular imaging devices for medical use for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies, automated and non-automated microscopy devices for medical use for use in analyzing and providing medical diagnostic test results in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance, and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies, automated and non-automated imaging analysis devices for clinical and medical laboratory use for use in preparing, enriching, concentrating, testing, analysing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies
Goods and ServicesScientific analysis in the fields of chemistry, biology and molecular biology; laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and medical diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services
Goods and ServicesMedical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 6, 2015
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 6, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 6, 2015
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 6, 2015
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 6, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 6, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoche mtm laboratories AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party Namemtm laboratories AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party Namemtm laboratories AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Friday, October 26, 2018UNDELIVERABLE MAIL - NO ACTION TAKEN
Thursday, September 20, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, September 20, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, February 5, 2016TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, January 14, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, January 14, 2016INVALIDATION PROCESSED
Friday, November 6, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 6, 2015CANCELLED SECTION 71
Sunday, December 30, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 2, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, November 17, 2008FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 17, 2008FINAL DISPOSITION PROCESSED
Wednesday, October 29, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 29, 2008REGISTERED-PRINCIPAL REGISTER
Friday, June 20, 2008EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, February 13, 2008EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 5, 2008PUBLISHED FOR OPPOSITION
Wednesday, January 16, 2008NOTICE OF PUBLICATION
Thursday, January 3, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 3, 2008ASSIGNED TO LIE
Thursday, November 15, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 15, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, November 15, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 15, 2007EXAMINERS AMENDMENT E-MAILED
Thursday, November 15, 2007EXAMINERS AMENDMENT -WRITTEN
Thursday, November 15, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 13, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 13, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 13, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 1, 2007REFUSAL PROCESSED BY IB
Friday, May 11, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 11, 2007REFUSAL PROCESSED BY MPU
Thursday, May 3, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 2, 2007NON-FINAL ACTION WRITTEN
Friday, April 27, 2007ASSIGNED TO EXAMINER
Friday, April 27, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, April 26, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB